Target intelligence / Profile preview

Phosphatase (null)

Target
null
Molecular classification
Enzyme, Hydrolase, Protein phosphatase, Protein tyrosine phosphatase, Protein serine/threonine phosphatase, Dual specificity phosphatase, Carbohydrate phosphatase, Nucleotidase, Lipid phosphatase
01

Overview

Phosphatases are a broad class of enzymes that catalyze the hydrolytic removal of phosphate groups from a variety of molecules, including proteins, nucleotides, lipids, and carbohydrates. They play critical roles in cellular regulation by reversing the actions of kinases and controlling signal transduction pathways, metabolism, cell cycle, apoptosis, and other physiological processes. Protein phosphatases, in particular, are divided into major subclasses such as serine/threonine phosphatases, tyrosine phosphatases, and dual specificity phosphatases, each recognizing different phosphorylated amino acid substrates. Because of their wide distribution and substrate specificity, phosphatases are essential for modulating cell function, but the use of "phosphatase" as a drug target is generally too broad, as therapeutics are developed against specific phosphatase subtypes (e.g., calcineurin, PP1, PTP1B) rather than the general class

Other names
Phosphatasesprotein phosphatasePPprotein tyrosine phosphatase (PTP)serine/threonine phosphataseacid phosphatasealkaline phosphatasedual specificity phosphataselipid phosphatasenucleotidasecarbohydrate phosphatase
02

Mechanism of action

Inhibition of dephosphorylation of target proteins (e.g., phosphatase inhibitors block removal of phosphate groups, sustaining phosphorylation-dependent signaling) Activation or inhibition of metabolic or signaling pathways through modulation of protein phosphorylation status

03

Biological functions

Signal transductionCell cycle regulationMetabolismApoptosisImmune responseCell proliferationCell differentiationCellular stress response
04

Disease associations

CancerDiabetesNeurodegenerative diseasesCardiovascular diseasesImmunological disordersMetabolic disorders
05

Safety considerations

Off-target effects due to broad enzyme familyRisk of immunosuppression (e.g., calcineurin inhibition)Effects on normal metabolic or signaling pathways, leading to toxicityRisk of developmental or homeostatic disruptions
06

Interacting drugs

Cyclosporine (targets calcineurin, a protein phosphatase 2B)

3 more in the full profile.

07

Biomarkers

Alkaline phosphatase levels (used clinically in liver, bone, and certain cancer conditions)Protein tyrosine phosphatase or specific phosphatase isoform expression (e.g., in tumors or metabolic disease)

Beyond the preview

Go deeper on Phosphatase (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phosphatase (null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call